✦ LIBER ✦

Cabergoline: A long-acting dopamine agonist in Parkinson's disease

✍ Scribed by G. Lera; J. Vaamonde; J. Muruzabal; J. A. Obeso

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 244 KB
Volume: 28
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410280429

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Parkinson's disease should

Treatment of Parkinson's disease should begin with a dopamine agonist

✍ Jean Louis Montastruc; Olivier Rascol; Jean-Michel Senard 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

Treatment of Parkinson's disease should

Treatment of Parkinson's disease should begin with a dopamine agonist

✍ Jean-Louis Montastruc 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

The effect of dopamine agonist therapy o

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease

✍ J. Eric Ahlskog; Ryan J. Uitti; Michael K. O'Connor; Demetrius M. Maraganore; Jo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

The use of dopamine agonists in very eld

The use of dopamine agonists in very elderly patients with Parkinson's disease

✍ Lisa M. Shulman; Alireza Minagar; Alejandro Rabinstein; William J. Weiner 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB 👁 2 views

Rationale for the use of dopamine agonis

Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease

✍ Anthony H. V. Schapira; C. Warren Olanow 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Intraventricular infusion of dopamine in

Intraventricular infusion of dopamine in Parkinson's disease

✍ Dr M. K. Horne; E. G. Butler; B. S. Gilligan; J. Wodak; R. J. Stark; G. A. Braze 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views